Literature DB >> 17053344

Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004.

Joris Hemelaar1, Eleanor Gouws, Peter D Ghys, Saladin Osmanov.   

Abstract

OBJECTIVE: To estimate the global and regional distribution of HIV-1 subtypes and recombinants in 2004.
DESIGN: A study was conducted in which molecular epidemiological data on HIV-1 subtype distribution in individual countries were combined with country-specific estimates of the number of people living with HIV.
METHODS: HIV-1 subtype data were collected for 23 874 HIV-1 samples from 70 countries, which together accounted for 89% of all people living with HIV worldwide in 2004. The proportions of HIV-1 infections due to various subtypes detected in each country were combined with the number of HIV infected people in the respective countries to generate regional and global HIV-1 subtype distribution estimates.
RESULTS: Subtype C accounted for 50% of all infections worldwide in 2004. Subtypes A, B, D and G accounted for 12%, 10%, 3% and 6%, respectively. The subtypes F, H, J and K together accounted for 0.94% of infections. The circulating recombinant forms CRF01_AE and CRF02_AG each were responsible for 5% of cases, and CRF03_AB for 0.1%. Other recombinants accounted for the remaining 8% of infections. All recombinant forms taken together were responsible for 18% of infections worldwide.
CONCLUSION: Combining data on HIV-1 subtype distribution in individual countries with country-specific estimates of the number of people living with HIV provided a good method to generate estimates of the global and regional HIV-1 genetic diversity in 2004. The results could serve as an important resource for HIV scientists, public health officials and HIV vaccine developers.

Entities:  

Mesh:

Year:  2006        PMID: 17053344     DOI: 10.1097/01.aids.0000247564.73009.bc

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  236 in total

1.  Impact of the HIV Tat C30C31S dicysteine substitution on neuropsychological function in patients with clade C disease.

Authors:  Robert H Paul; John A Joska; Carol Woods; Soraya Seedat; Susan Engelbrecht; Jacqueline Hoare; Jodi Heaps; Victor Valcour; Beau Ances; Laurie M Baker; Lauren E Salminen; Dan J Stein
Journal:  J Neurovirol       Date:  2014-11-01       Impact factor: 2.643

2.  Characterization of primary isolates of HIV type 1 CRF28_BF, CRF29_BF, and unique BF recombinants circulating in São Paulo, Brazil.

Authors:  Fernando Lucas Melo; Leda Fátima Jamal; Paolo Marinho de Andrade Zanotto
Journal:  AIDS Res Hum Retroviruses       Date:  2012-04-16       Impact factor: 2.205

3.  Inconsistencies in estimating the age of HIV-1 subtypes due to heterotachy.

Authors:  Joel O Wertheim; Mathieu Fourment; Sergei L Kosakovsky Pond
Journal:  Mol Biol Evol       Date:  2011-10-31       Impact factor: 16.240

4.  Phylodynamic and phylogeographic patterns of the HIV type 1 subtype F1 parenteral epidemic in Romania.

Authors:  Jean L Mbisa; Stéphane Hué; Andrew J Buckton; Richard E Myers; Dan Duiculescu; Luminita Ene; Cristiana Oprea; Gratiela Tardei; Sorin Rugina; Mariana Mardarescu; Corinne Floch; Gundula Notheis; Bettina Zöhrer; Patricia A Cane; Deenan Pillay
Journal:  AIDS Res Hum Retroviruses       Date:  2012-05-03       Impact factor: 2.205

5.  Near full-length genomic characterization of a HIV type 1 BC recombinant strain from Manipur, India.

Authors:  Roni Sarkar; Kamalesh Sarkar; N Brajachand Singh; Y Manihar Singh; Sekhar Chakrabarti
Journal:  Virus Genes       Date:  2012-06-19       Impact factor: 2.332

6.  The effect of clade-specific sequence polymorphisms on HIV-1 protease activity and inhibitor resistance pathways.

Authors:  Rajintha M Bandaranayake; Madhavi Kolli; Nancy M King; Ellen A Nalivaika; Annie Heroux; Junko Kakizawa; Wataru Sugiura; Celia A Schiffer
Journal:  J Virol       Date:  2010-07-21       Impact factor: 5.103

7.  Conserved determinants of enhanced CCR5 binding in the human immunodeficiency virus subtype D envelope third variable loop.

Authors:  Samaporn Teeravechyan; M Essex; Tun-Hou Lee
Journal:  AIDS Res Hum Retroviruses       Date:  2010-04       Impact factor: 2.205

8.  Patients infected with HIV type 1 subtype CRF01_AE and failing first-line nevirapine- and efavirenz-based regimens demonstrate considerable cross-resistance to etravirine.

Authors:  Weerawat Manosuthi; David M Butler; Wasun Chantratita; Chonlaphat Sukasem; Douglas D Richman; Davey M Smith
Journal:  AIDS Res Hum Retroviruses       Date:  2010-06       Impact factor: 2.205

9.  Impact of HIV type 1 subtype on drug resistance mutations in Nigerian patients failing first-line therapy.

Authors:  B Chaplin; G Eisen; J Idoko; D Onwujekwe; E Idigbe; I Adewole; W Gashau; S Meloni; A D Sarr; J L Sankalé; E Ekong; R L Murphy; P Kanki
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-21       Impact factor: 2.205

10.  Short communication: antiretroviral therapy resistance mutations present in the HIV type 1 subtype C pol and env regions from therapy-naive patients in Zambia.

Authors:  Sandra Gonzalez; Clement Gondwe; Damien C Tully; Veenu Minhas; Danielle Shea; Chipepo Kankasa; Tendai M'soka; Charles Wood
Journal:  AIDS Res Hum Retroviruses       Date:  2010-07       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.